Predicting the General Self-Efficacy of the People with Diabetes in Bandargaz- 2023: The Role of Rumination and Alexithymia

Objective: This study aimed to investigate the impact of rumination and alexithymia on the general self-efficacy of individuals with diabetes. Materials and Methods: This correlational study targeted diabetic individuals aged 30–50 years residing in Bandargaz in 2023. A total of 217 participants were selected through convenience sampling. Data collection instruments included the General Self-Efficacy Scale (GSES), the Ruminative Response Scale (RRS), and the Toronto Alexithymia Scale (TAS). Data were analyzed using SPSS version 24, employing Pearson’s correlation coefficient and stepwise regression analysis. Results: The results revealed a significant negative relationship between alexithymia and general self-efficacy. In the first step of the regression analysis, the beta coefficient was -0.446, indicating that a one standard deviation increase in alexithymia was associated with a 0.446 standard deviation decrease in general self-efficacy. In the second step, the beta coefficient for rumination was -0.152, suggesting that a one standard deviation increase in rumination was associated with a 0.152 standard deviation decrease in general self-efficacy. Conclusion: The findings demonstrate that higher levels of alexithymia and rumination negatively affect general self-efficacy in individuals with diabetes. Educational interventions and workshops focused on improving emotional regulation and cognitive coping strategies could enhance self-efficacy, enabling individuals to achieve personal goals and improve their overall well-being.